FDA PO
US Food and Drug Administration
Dr. Tannaz Ramezanli is a senior pharmacologist within the Office of Research and Standard (ORS) at Office of Generic Drugs (OGD). She specializes in topical and transdermal products. She is a senior reviewer for the development of product-specific bioequivalence guidances, responding to controlled correspondences, citizen petitions, and Pre-ANDA meeting packages. She leads several regulatory science research initiatives related to development of bioequivalence standards for complex topical drug products through FDA-funded collaborations with research institutions around the world. She received her Ph.D. in Pharmaceutical Sciences from Rutgers University and her Pharm.D. from Tehran University of Medical Sciences.